Cargando…
Rational dosing of gabapentin and pregabalin in chronic kidney disease
Autores principales: | Raouf, Mena, Atkinson, Timothy J, Crumb, Meredith W, Fudin, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291335/ https://www.ncbi.nlm.nih.gov/pubmed/28184168 http://dx.doi.org/10.2147/JPR.S130942 |
Ejemplares similares
-
Gabapentinoids: Gabapentin and Pregabalin for Postoperative Pain Management
por: Imani, Farnad, et al.
Publicado: (2012) -
Can we not work together to help family practitioners become more effective pain managers?
por: Fudin, Jeffrey, et al.
Publicado: (2016) -
OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form
por: Fudin, Jeffrey, et al.
Publicado: (2016) -
Safety concerns with the Centers for Disease Control opioid calculator
por: Fudin, Jeffrey, et al.
Publicado: (2017) -
Mirogabalin: could it be the next generation gabapentin or pregabalin?
por: Kim, Jae-Yeon, et al.
Publicado: (2021)